The Centre will enhance Australian clinical immunisation research and training, focussing upon clinical questions with translatable outcomes not easily addressed by industry. Optimal immunisation and interventions to maximise uptake of existing and new vaccines in high risk patient groups, such as children with cancer, immigrants, children with chronic diseases and adolescents will be studied. New vaccine trials, innovative use of existing vaccines, systematic collection of vaccine failure data, ....The Centre will enhance Australian clinical immunisation research and training, focussing upon clinical questions with translatable outcomes not easily addressed by industry. Optimal immunisation and interventions to maximise uptake of existing and new vaccines in high risk patient groups, such as children with cancer, immigrants, children with chronic diseases and adolescents will be studied. New vaccine trials, innovative use of existing vaccines, systematic collection of vaccine failure data, and targeted epidemiology and disease modelling vaccine preventable disease will also allow a broad program of research, enabling training and mentoring of young clinical nurse and physician researchers. Collaborations with existing national immunisation, infectious diseases and research institutions will allow maximal effectiveness of clinical studies.Read moreRead less
Generation Of Protective Immunity Against Severe Influenza Disease In Indigenous Australians
Funder
National Health and Medical Research Council
Funding Amount
$1,630,970.00
Summary
Hospitalisation and death rates from influenza are high in the Indigenous population, especially when a new virus emerges. There is an urgent need for a vaccine that protects against all influenza strains. T cells recognising conserved viral regions elicit such protection. As T cells are restricted by proteins called HLAs, which vary across ethnicities, we will define T cell regions for HLAs prominent in Indigenous Australians and define how to generate protective immunity against influenza.
A Study To Investigate Alternative Regimens For Pneumococcal Vaccination Of Infants In A Developing Country
Funder
National Health and Medical Research Council
Funding Amount
$1,622,210.00
Summary
Streptococcus pneumoniae (Pnc) is the leading vaccine preventable cause of serious infection in infants. The current Pnc conjugate vaccine is very expensive (approximately USD $200-infant) so it is unlikely to be affordable for most developing countries. Moreover, as health care access in developing countries may be episodic and unreliable, many children do not receive either complete or timely vaccine courses. Therefore, it is important to investigate affordable and flexible ways to deliver thi ....Streptococcus pneumoniae (Pnc) is the leading vaccine preventable cause of serious infection in infants. The current Pnc conjugate vaccine is very expensive (approximately USD $200-infant) so it is unlikely to be affordable for most developing countries. Moreover, as health care access in developing countries may be episodic and unreliable, many children do not receive either complete or timely vaccine courses. Therefore, it is important to investigate affordable and flexible ways to deliver this vaccine, which are safe and effective. A recent WHO-GAVI meeting to address impediments to the introduction of these vaccines in developing countries recognized the need to evaluate other regimens of Pnc conjugate vaccine as an important research priority. This study has been deliberately formulated with that need in mind. The site for this research is Fiji. Although health services are good, Pnc disease, particularly pneumonia, remains the commonest cause of childhood morbidity and mortality. Fiji has good vaccine coverage and was the first Pacific country to introduce Hib vaccine. The arrival of the new, expensive Pnc conjugate vaccine presents a dilemma for Fiji and many similar countries. The expense of this vaccine would consume a large portion of the health budget. This study has two components: 1. A Phase 2 immunogenicity study (involving 750 infants) to evaluate regimens using reduced numbers of doses of Pnc conjugate vaccine, and using timing of dosing and combinations with the Pnc polysaccharide (PS) vaccine that may be more suited to the epidemiology of Pnc disease in developing countries. 2. An epidemiological study will measure the burden of invasive Pnc disease and pneumonia in Fiji. This will be part of a global effort to address these issues, and will be used to develop rapid assessment tools for these diseases in developing countries. We will seek cofounding for this component.Read moreRead less
Impact Of DTP Schedules On The Immunogenicity Of 2 Doses Of 13v-PCV Followed By An Early Booster
Funder
National Health and Medical Research Council
Funding Amount
$2,651,687.00
Summary
This project aims to come up with a vaccination schedule to make pneumococcal vaccines more effective and affordable for Fiji and other developing countries. We will evaluate schedules involving a 2 dose primary series in early infancy with a booster at 9 months of age. We will compare the immune responses to 3 different primary series and 2 booster options. The results of this project will be used to provide advice, at global and country levels, regarding introduction of pneumococcal vaccines.
Do marine heat waves cause pathogen outbreaks in Australian coastal waters? This project aims to identify links between increasingly frequent Marine Heat Wave (MHW) events and outbreaks of microbes that cause disease in marine animals, reduced aquaculture yields and human health hazards. Pathogenic bacteria from the Vibrio genus exhibit a preference for elevated seawater temperature and this project will test the hypothesis that episodic MHWs will trigger blooms of dangerous species. Using innov ....Do marine heat waves cause pathogen outbreaks in Australian coastal waters? This project aims to identify links between increasingly frequent Marine Heat Wave (MHW) events and outbreaks of microbes that cause disease in marine animals, reduced aquaculture yields and human health hazards. Pathogenic bacteria from the Vibrio genus exhibit a preference for elevated seawater temperature and this project will test the hypothesis that episodic MHWs will trigger blooms of dangerous species. Using innovative ecogenomic tools, this project will track the impact of MHWs on the dynamics of pathogenic Vibrio within coastal habitats, oyster farming facilities and coral reefs. The benefit of this project will be essential new knowledge on an emerging threat to Australia’s valuable marine estate, food security and public health.Read moreRead less
Australian savannah landscapes: past, present and future. Australian savannahs are productive and culturally and biologically significant landscapes but are vulnerable to climate change. The project will determine savannah function (carbon and water balance) for the present and assess how sensitive they have been to past climate variability. The project will then address how they may respond to future climate change.
Vulnerability of Australian savannas to climate change and variability. Australian savannas are productive and are culturally and biologically significant landscapes, but they are vulnerable to climate change. This project will determine savanna function (carbon and water balance) for the present and assess how sensitive they have been to past climate variability. The project will then address how they may respond to future climate change.
Are evolutionary refugia traps for endemic species? This project aims to determine whether species that have small geographic ranges and which live in historically stable refugia have evolved narrow climatic tolerances. The project will compare such species with more widespread, related species living in the same areas and combine field- and lab-based estimates of physiological tolerances with genomic estimates of population history and diversity. The expected outcome is to test the prediction f ....Are evolutionary refugia traps for endemic species? This project aims to determine whether species that have small geographic ranges and which live in historically stable refugia have evolved narrow climatic tolerances. The project will compare such species with more widespread, related species living in the same areas and combine field- and lab-based estimates of physiological tolerances with genomic estimates of population history and diversity. The expected outcome is to test the prediction from evolutionary theory that small-range, refugial species are intrinsically more sensitive to climatic change. The project expects to provide improved guidance for ecological management of biodiversity hotspots.Read moreRead less
Either side of the Big Wet: the future resilience of south-eastern Australia's biota. Australia must develop strategies for managing its biodiversity under climate changes expected to occur under projected Intergovernmental Panel on Climate Change (IPCC) emission scenarios. The project will furnish comprehensive data on the response of plants and animals to the break in the Big Dry (1997-2009) in 2010-11 and evaluate how predict biotic components will cope with future climates.